FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to the field of medicine and pharmaceutics, namely to the use of the lipid fraction of Anfeltia Tobuchinsky thallus extract - Ahnfeltia tobuchiensis (Kanno et Matsubara) Makijenko, department Rodophyta, order Ahnfeltiales, family Ahnfeltiaceae, as a lipid-correcting agent in alimentary dyslipidemia.
EFFECT: reduced content of triacylglycerols, total cholesterol in blood, low-density lipoprotein cholesterol and atherogenicity index with increase of content of high-density lipoprotein cholesterol in blood.
1 cl, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
HEPATOPROTECTIVE AGENT FROM ALGAE | 2017 |
|
RU2667472C1 |
METHOD FOR DISLIPIDEMIA PREVENTION | 2016 |
|
RU2621152C1 |
AGENT WITH LIPID-CORRECTING AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2309763C2 |
METHOD FOR STEP-BY-STEP MODELING OF NONALCOHOLIC FATTY PANCREATIC DISEASE IN RATS | 2021 |
|
RU2770555C1 |
METHOD OF SIMULATING MULTIPLE ORGAN PATHOLOGY IN RATS | 2011 |
|
RU2453002C1 |
PREPARATION BEING OF LIPID-CORRECTING, HYPOCOAGULATIVE AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2302248C2 |
METHOD OF REGULATING ANTIGEN IMMUNOGENICITY | 2010 |
|
RU2440141C1 |
AGENT POSSESSING HYPOLIPIDEMIC ACTIVITY | 2020 |
|
RU2732503C1 |
METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
METHOD OF MODELING NON-ALCOHOLIC STEATOHEPATITIS IN RATS | 2009 |
|
RU2394281C1 |
Authors
Dates
2022-03-22—Published
2021-04-30—Filed